Navigation Links
CellHealth Institute Launches New Cell Health Formula
Date:5/1/2013

MONTCLAIR, N.J., May 1, 2013 /PRNewswire/ -- CellHealth™ Institute, a biotechnology company focused on cellular health, research and holistic lifestyle education, today launched its cell health formula, everycell™.

(Photo: http://photos.prnewswire.com/prnh/20130501/LA05313)

(Logo: http://photos.prnewswire.com/prnh/20130327/LA84207LOGO)

Developed by a team of cell health and aging experts, and in partnership with GMP manufacturers, everycell contains more than 90 essential phytonutrients, vitamins and minerals that the body needs to function optimally. Using natural ingredients including Fruitura™ and Aquamin™, the proprietary complexes of everycell deliver these nutrients to a person's cells, helping to create the ideal cellular environment to support a healthy lifestyle.

The everycell formula has seven unique complexes that support: cell regulation; free radical scavenging; DNA repair; telomere maintenance; stem cell maintenance; calorie restriction, digestion and absorption. These complexes were perfected over time by CellHealth Institute scientists to address the intricate infrastructure of cell health, including cell repair, aging, and replication, which directly affect the body's ability to function on a day-to-day basis.

"The trillions of cells that make up the human body determine the state of a person's health," said Dr. Vincent Giampapa, CellHealth Institute's chief medical officer. "Simply stated, when our cells are healthy, we are healthy. The everycell formula is specifically designed to take daily—morning and night—to provide the natural plant-derived complexes needed to help people work, play and rest at their optimal level. It's no longer simply about the vitamins and minerals, but about creating the cellular environment for those nutrients to be utilized most effectively."

The "awake" and "asleep" formulas are designed to take in the morning and evening each day to help optimize cell efficiency during the different parts of the day.

David Saloff, chief executive of CellHealth Institute, said, "We are committed to developing and delivering the highest quality products and services that will enable and empower people to live healthier lives for longer. We live in an era where we're increasingly affected by toxicity in the environment, our diets and lifestyles. But it's also an exciting era, where technological advancement and scientific research are giving us the tools to maintain and improve our health. And everycell is our gateway formula to improved cell health."

The everycell formula comes in packages of 120 tablets – 60 "awake" and 60 "asleep" -- and is available for purchase at everycell.com for $79 per month as part of a continuity program.

For more information, or to purchase, visit everycell.com.

About CellHealth™ Institute

CellHealth Institute (CHI) is a biotechnology company focused on cellular health that integrates breakthrough products and services with holistic lifestyle education. CHI collaborates with top-tier research universities and publicly traded biotech companies to offer fully integrated personalized health programs paired with scientific biomarker evaluations, as well as medical-grade supplements, including everycell™, and advanced treatment through stem cell therapies. The organization is headquartered in New Jersey with an international regenerative medicine destination in Costa Rica set to open in 2014. CHI services and products allow people to take control of their own health at the most basic level – their cells.

 

 


'/>"/>
SOURCE CellHealth Institute
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. CellHealth Institute Launches with Support from Influential Investors
2. Masaryk Memorial Cancer Institute Reduces Losses and Administrative Overhead With Ekahau RTLS
3. Van Andel Institute Partners with UNCF to Recruit Students to Biomedical Research Careers
4. The Pharmabiotic Research Institute (PRI) is Preparing to Publish its First Works on the Therapeutic and Medicinal Potential of Probiotics
5. Michael A. Marletta Takes Office as New President of Scripps Research Institute
6. HealthCare Institute of New Jersey Releases 2011 Biopharmaceutical and Medical Technology Economic Impact Data
7. QIAGEN and Max Planck Institute for Infection Biology Collaborate to Develop Assay for Active TB Risk in Individuals With Latent Infection
8. DFH Pharma to Collaborate With National Cancer Institute to Develop Second-Generation HIV Maturation Inhibitor Drugs
9. Niels Bohr Institute gets top researcher from Harvard
10. Van Andel Research Institute Study Provides New Details of Fundamental Cellular Process
11. Lupus Research Institute Awards $3.6 Million for Novel Studies Driving Wide-Ranging New Science in Lupus
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/9/2016)... 2016 According to a new market research ... Predesigned, Reagent Equipment), Application (Research, PCR, Gene, DNA, NGS, Diagnostic, RNAI), ... MarketsandMarkets, the global market is expected to reach USD 2.20 Billion ... of 10.6% during the forecast period. ... ...
(Date:12/8/2016)... 2016 This report analyzes the worldwide markets for ... (Humic, Amino, & Fulvic), Extract Based, and Others. The report ... Ornamental & Turf, Row Crops, and Others. The report provides ... , Japan , Europe ... , and Rest of World. Annual estimates and forecasts ...
(Date:12/8/2016)... DIEGO, Dec. 8, 2016  OncoSec Medical Incorporated ... developing DNA-based intratumoral cancer immunotherapies, today announced financial ... "We are delivering on our commitment ... with ImmunoPulse® IL-12. We are pleased with the ... combination trial, and we are focused on advancing ...
(Date:12/8/2016)... India , December 8, 2016 ... a comprehensive analysis, titled Global Amyloglucosidase Industry 2016 Market Research ... classification, application, and industry chain overview are all covered in ... SWOT analysis, and investment return analysis of the Amyloglucosidase industry. ... , , ...
Breaking Biology Technology:
(Date:12/6/2016)... 6, 2016  Zimmer Biomet Holdings, Inc. (NYSE and SIX: ... offering of €500.0 million principal amount of its 1.414% senior ... its 2.425% senior unsecured notes due 2026. ... December 13, 2016, subject to the satisfaction of customary closing conditions.  ... The Company intends to use the ...
(Date:12/6/2016)... , Dec. 6, 2016 Securus ... justice technology solutions for public safety, investigation, corrections ... jointly announced today a five (5) year funding ... agreement to expand the rehabilitation and reentry support ... PEP History Established in 2004, the Prison Entrepreneurship ...
(Date:12/2/2016)... India , December 1, 2016 ... Authentication type (Fingerprint, Voice), Future Technology (Iris Recognition ... and Region - Global Forecast to 2021", published ... USD 442.7 Million in 2016, and is projected ... at a CAGR of 14.06%.      ...
Breaking Biology News(10 mins):